MedTrace Logo

A Trial of HR021618 in Postsurgical Pain Management

NCT04699175 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2021-08-06

No results posted yet for this study

Summary

The study is being conducted to evaluate the efficacy, safety of HR021618 and to explore the reasonable dosage of HR021618 for Pain Management after Orthopaedic surgery.

Conditions

  • Postsurgical Pain Management

Interventions

DRUG

HR021618

Treatment group A:HR021618; high dose

DRUG

HR021618

Treatment group B:HR021618; low dose

DRUG

Placebo

Treatment group C: HR021618 blank preparation.

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-17
Primary Completion
2021-08-03
Completion
2021-08-08

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04699175 on ClinicalTrials.gov